Australia markets closed

Asensus Surgical, Inc. (ASXC)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.2600-0.0015 (-0.57%)
At close: 04:00PM EDT
0.2685 +0.01 (+3.27%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 71.21M
Enterprise value 68.68M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.72
Price/book (mrq)5.47
Enterprise value/revenue 7.87
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-54.39%
S&P500 52-week change 326.36%
52-week high 30.6500
52-week low 30.2000
50-day moving average 30.2608
200-day moving average 30.2765

Share statistics

Avg vol (3-month) 31.6M
Avg vol (10-day) 3957.85k
Shares outstanding 5272.31M
Implied shares outstanding 6272.31M
Float 8266.86M
% held by insiders 12.05%
% held by institutions 19.21%
Shares short (30 Apr 2024) 416.1M
Short ratio (30 Apr 2024) 46.76
Short % of float (30 Apr 2024) 46.03%
Short % of shares outstanding (30 Apr 2024) 45.91%
Shares short (prior month 28 Mar 2024) 417.75M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 312 Dec 2019
Ex-dividend date 4N/A
Last split factor 21:13
Last split date 312 Dec 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,616.56%

Management effectiveness

Return on assets (ttm)-67.39%
Return on equity (ttm)-169.75%

Income statement

Revenue (ttm)8.72M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)15.10%
Gross profit (ttm)N/A
EBITDA -70.28M
Net income avi to common (ttm)-78.71M
Diluted EPS (ttm)-0.3000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.99M
Total cash per share (mrq)0.03
Total debt (mrq)5.46M
Total debt/equity (mrq)41.89%
Current ratio (mrq)1.00
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)-60.39M
Levered free cash flow (ttm)-23.1M